Data Access and Use. The School agrees to allow the Sponsor access to its facilities and records to review data sources, including collection and recording procedures, in order to assist the Sponsor in making a valid determination as to whether student performance requirements have been met as stated in the Charter, and as required by Sections 1008.31 and 1008.345, Florida Statutes. The School must use the Sponsor’s student information system and the Sponsor agrees to provide the School with sufficient access to such student information system. The School agrees to utilize data provided by the Sponsor in its electronic data processing systems pertaining to admissions, registration, and student records. The School shall also use records and grade procedures that adequately provide the information required by the Sponsor. If the School chooses to use an alternate grade book system other than the Sponsor’s, the Sponsor will not be required to provide any technical support. The Sponsor will provide services/support activities which are routinely provided to the Sponsor’s staff regarding implementation of state-required assessment activities (e.g., staff-training, dissemination and collection of materials, monitoring, scoring, analysis and summary reporting). Student performance data for each student in the School, including, but not limited to, state mandated assessment scores, standardized test scores, previous public school student report cards, and student performance measures, shall be provided by the Sponsor to the School in the same manner provided to other public schools in the district. Any expense for the aforementioned services that is not included as part of the Sponsor’s administration fee under Section 1002.33(20), Florida Statutes, will be the responsibility of the School.
Data Access and Use. (1) The School shall, at its own expense, maintain connection to the Sponsor’s mainframe for reporting student information, and timely and fully report all student information (including absences, disciplinary matters, grades, and all other student information required by law). The School shall report disciplinary incidents by the end of the month the incident occurred. The School shall report weekly attendance by Tuesday of the following week. The Sponsor shall provide reasonable access to its mainframe and XXXX system. The School shall maintain appropriate hardware, and agree to participate in Sponsor training. The School shall submit all student record information required by law in accordance with the FDOE’s guidelines for electronic data formats. The data elements shall include but not be limited to, the following: ESE data; grade level assignment; Required health information; Required discipline codes/incident data; daily attendance; transportation; student schedules; teacher demographics; master schedule; ESOL/migrant codes; grades/grading period/grading scale; ERW (entry, re-entry, withdrawal) information; test scores; demographic information; academic history and transcripts; 504 data; and student lunch information if required. The Sponsor shall grant access, at no expense to the School, to the electronic management system used by the Sponsor to develop and maintain IEPs/EPs.
(2) The School agrees to allow the Sponsor reasonable access to its facilities and records to review data sources, including collection and recording procedures, in order to assist the Sponsor in making a valid determination about the degree to which student performance requirements have been met required by s. 1002.33(23), F.S.
(3) Sponsor is required to provide to the State Board of Education and the Commissioner of Education an analysis and comparison of the overall performance of the School's students. The parties agree that the Sponsor will use results from the State required assessment programs referenced in this Contract (and any of Sponsor’s assessment programs in which the School elects to participate) in a disaggregated format and the data elements to be included in the Annual Report which the School is required to submit pursuant to s. 1002.33(23), F.S.
(4) The School shall input demographic enrollment data in the XXXX system, which shall include the student's at-risk status if applicable.
(5) Failure to update and maintain student information may result in Sponsor...
Data Access and Use. 2.1.1. You acknowledge that once you have consented to our terms and conditions, our office could contact you with the objective to assist in educating you on your financial affairs and provide information and assistance on how you could improve your credit score. In addition to this and with your consent, should we believe there are good economic products available which could be valuable to you also introduce these products on a no obligation basis.
2.1.2. We will comply with all legislation applicable to your business, specifically the Credit Regulatory Framework;
2.1.3. We will use Consumer Credit Information for a Prescribed Purpose or such other purpose that may be permitted in terms of the Credit Regulatory Framework;
2.1.4. Prior to requesting and accessing Consumer Credit Information, including accessing the information for the purpose of risk assessment and sharing payment profiles with credit providers, we will comply with the requirements of the Credit Regulatory Framework, specifically obtaining Consent from the Consumer as and when required;
2.1.5. We will ensure that we obtain the necessary Consent from you the Consumer when required;
2.1.6. We will adhere to all the relevant sections of the Act, together with any Regulations issued in terms thereof, where we are provided with any data in terms of this Agreement for the purpose of providing advice on services;
2.1.7. We will comply and implement the regulatory requirements in terms of all relevant legislation (including the Credit Regulatory Framework), as and when amended and enacted;
2.1.8. We further agree to co-operate with you and the Payment Profile Credit Bureaux to assist us and them to meet the requirements of the Credit Regulatory;
2.1.9. If you are a consumer and the report is provided directly to you, you hereby consent that we may obtain the report on your behalf and deliver it directly to you in the manner and form authorised by you, which may include to email, SMS or WhatsApp the report directly to you or to provide you with access to our online platform where you may obtain your report.
Data Access and Use. (A) The data generated by the IC under this Agreement are the property of IC. IC will provide Entity with copies of Study Data (which exclude Identifiable Private Information), if requested, but access and review of Raw Data will only be in accordance with the restrictions under this Article 7. If Entity requires Study Data to be reformatted, it is understood that IC will not expend resources to reformat the Study Data. Entity may directly provide funds to IC’s contractor for the cost of this reformatting. In no event shall the payment of these costs by Entity be considered a receipt, payment or credit under the IC contractor’s contract with the government. This transaction between the Entity and IC’s contractor must occur outside of, and irrespective of, the contractor’s contract with the government.
(B) The Study Data provided by IC or IC’s contractor to Entity may be used by Entity for
(1) internal research purposes; (2) Test Article development purposes which may include work with third party collaborators, provided they are under obligations of confidentiality substantially similar to those set forth in this Agreement; (3) publications in accordance with the terms of Article 10 below; and (4) regulatory and patent filings.
(C) Entity may access and review Raw Data (which may include Identifiable Private Information) for the purposes of (1) on-site quality auditing and co-monitoring; (2) meeting the reporting requirements of the FDA or other U.S. or foreign health authorities; or (3) internal research purposes directly related to obtaining regulatory approval of the Test Article. Additionally, Entity’s access, review, receipt, or use of such information is limited to the permissions explicitly contained in the patient informed consent form.
Data Access and Use. Correction:
Data Access and Use. Hospital agrees to submit data to BioSense 2.0 in accordance with the terms and conditions herein. Hospital shall not take any actions inconsistent with this Agreement; Hospital shall not submit data to BioSense 2.0 that it is not authorized to submit; and Hospital submission of data will comply with applicable federal, state, and local laws. Any violation of the aforementioned terms and conditions by Hospital may result in suspension or termination of the Hospital’s access to and/or use of BioSense 2.0.
1. The Hospital acknowledges and agrees that as part of BioSense 2.0, the Data may be used and/or disclosed for the following purposes:
a. Sole Use by DHW or PHDs in Secure Space. For use by DHW or PHDs for continued maintenance and control of data in BioSense
Data Access and Use. The “Data Access and Use Committee” will perform the following activities and make the following recommendations in furtherance of the LDS Functions:
a. Working in coordination with the Legal Controls Committee, recommend intake, tracking, and review procedures for External Data Sharing Requests, as defined in Section VII of this Agreement;
b. Recommend methods and criteria for prioritizing the review and processing of External Data Sharing Requests;
c. Recommend to the LDS Agencies policies and criteria for approving or disapproving External Data Sharing Requests;
d. Interfacing with the Illinois Collaborative for Education Policy Research (ICEPR) and the Illinois Education Research Council (IERC) to facilitate access to Restricted Data to support overall State research priorities; and
e. Providing technical expertise and consultation upon request of the LDS Agencies on External Data Sharing Requests.
Data Access and Use. Hospital agrees to submit data to the BioSense platform in accordance with the terms and conditions herein. Hospital shall not take any actions inconsistent with this Agreement; Hospital shall not submit data to the BioSense platform that it is not authorized to submit; and Hospital submission of data will comply with applicable federal, state, and local laws. Any violation of the aforementioned terms and conditions by Hospital may result in suspension or termination of Hospital’s access to and/or use of the BioSense platform.
1. Hospital acknowledges and agrees that as part of syndromic surveillance using the BioSense platform, the Data may be used and/or disclosed for the following purposes:
Data Access and Use. Participant shall access and use (and ensure that its Authorized Users access and use) Data obtained through the Virtua HIE only for Permitted Uses and within the scope of access applicable to the Participant User Type (e.g., Data Sharer, Data Receiver, Data Supplier) that the Participant registered as with the Virtua HIE.
Data Access and Use
